Transcatheter Embolization and Occlusion Devices Market
The transcatheter embolization and occlusion devices market is witnessing rapid advancements as minimally invasive therapies gain prominence across oncology, neurology, and vascular disease management. According to SNS Insider, the market size was valued at USD 5.46 billion in 2024 and is projected to reach USD 10.57 billion by 2032, growing at a CAGR of 8.66% during the forecast period of 2025–2032.
This accelerated growth reflects a global shift toward safer, catheter-based interventions that offer reduced recovery times, fewer complications, and better patient outcomes compared to open surgical procedures. Physicians and healthcare providers are increasingly adopting embolization techniques for tumor management, aneurysm repair, and treatment of vascular malformations, thereby reinforcing market momentum.
Get a Free Sample Report of Transcatheter Embolization and Occlusion Devices Market @ https://www.snsinsider.com/sample-request/7988
Growth Drivers
The growth of the transcatheter embolization and occlusion devices market is being shaped by several key drivers. Rising prevalence of cancer and neurological disorders has significantly boosted demand for embolization therapies, particularly in oncology where tumor devascularization is becoming a preferred treatment approach. According to WHO data, global cancer cases are expected to increase by more than 47% by 2040, underscoring the urgent need for advanced embolization technologies.
Technological innovations such as bioactive embolics, image-guided delivery systems, and next-generation detachable coils are further expanding clinical applications, improving precision, and enhancing patient safety. In addition, increasing investments in interventional radiology infrastructure across hospitals and ambulatory surgical centers are enabling broader access to these therapies.
Demographic factors also play a crucial role, with the growing aging population more prone to vascular diseases, aneurysms, and chronic conditions that require embolization procedures. Moreover, favorable reimbursement frameworks in developed economies and rising healthcare expenditures in emerging markets are driving adoption on a global scale. The shift toward outpatient procedures, supported by the growing presence of ambulatory surgical centers, is adding further impetus to the market’s expansion.
Key Segmentation Insights
By device type, the market is segmented into non-coil devices (including flow diverting devices, embolization particles, liquid embolics, and other types) and coils (pushable and detachable). Non-coil devices are increasingly preferred in complex vascular and oncology cases due to their high precision and long-term efficacy. Meanwhile, detachable coils continue to dominate neurovascular procedures because of their enhanced control and reliability during embolization.
In terms of applications, oncology remains the leading segment, driven by rising cancer prevalence and the growing role of embolization in targeted tumor treatment. Peripheral vascular disease and neurology also contribute significantly, with embolization being widely used for aneurysms, stroke prevention, and arteriovenous malformations. Emerging applications in urology and other specialized fields are further diversifying the market scope.
By end use, hospitals hold the largest market share, accounting for a substantial proportion of embolization and occlusion procedures due to their advanced infrastructure, skilled professionals, and integrated diagnostic support. However, ambulatory surgical centers are rapidly gaining traction as minimally invasive procedures shift to outpatient settings, offering cost-efficiency and faster turnaround times for patients.
Buy a Single-User PDF of Transcatheter Embolization and Occlusion Devices Market Analysis & Outlook Report @ https://www.snsinsider.com/checkout/7988
Regional Outlook
North America continues to dominate the global transcatheter embolization and occlusion devices market, supported by advanced healthcare systems, favorable reimbursement structures, and strong adoption of minimally invasive procedures. Europe follows closely with significant investments in interventional radiology. Meanwhile, the Asia Pacific region is expected to witness the highest growth rate, propelled by rising healthcare infrastructure, growing awareness, and an expanding patient population with chronic diseases.
Read Our Other Report
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Jagney Dave – Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: [email protected]
